Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS,…
INNSBRUCK, Austria, June 15, 2025 /PRNewswire/ -- "As cyberattacks evolve, detection can't be a checkbox. Our 2025 EDR/XDR Certification helps…